# Hemodynamic-GUIDEd Management of Heart Failure

Study · id `cardio:ct-nct03387813` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03387813](<https://clinicaltrials.gov/study/NCT03387813>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03387813

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2358 participants.

## Technical summary

Registry record NCT03387813. Randomized; single masking; primary purpose treatment. Start 2018-03-15 (actual); primary completion 2023-05-17 (actual). Results posted on 2025-08-07.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2358 participants (enrolled count; ClinicalTrials.gov record NCT03387813, source copy `cardio:ctgov-nct03387813-2025-08-07`, retrieved 2026-10-26)
- Started: 2018-03-15 (actual) (ClinicalTrials.gov record NCT03387813, source copy `cardio:ctgov-nct03387813-2025-08-07`, retrieved 2026-10-26)
- Primary completion: 2023-05-17 (actual) (ClinicalTrials.gov record NCT03387813, source copy `cardio:ctgov-nct03387813-2025-08-07`, retrieved 2026-10-26)
- Completion: 2023-05-17 (actual) (ClinicalTrials.gov record NCT03387813, source copy `cardio:ctgov-nct03387813-2025-08-07`, retrieved 2026-10-26)
- Results first posted: 2025-08-07 (ClinicalTrials.gov record NCT03387813, source copy `cardio:ctgov-nct03387813-2025-08-07`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT03387813, source copy `cardio:ctgov-nct03387813-2025-08-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03387813-2025-08-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Hemodynamic-GUIDEd Management of Heart Failure
- Acronym: GUIDE-HF
- Condition: Heart Failure
- Condition: Heart Failure, Systolic
- Condition: Heart Failure, Diastolic
- Condition: Heart Failure NYHA Class II
- Condition: Heart Failure NYHA Class III
- Condition: Heart Failure NYHA Class IV
- Condition: Heart Failure，Congestive
- Condition: Heart Failure With Reduced Ejection Fraction
- Condition: Heart Failure With Normal Ejection Fraction
- Condition: Heart Failure; With Decompensation
- Intervention (Device): CardioMEMS™ HF System
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart failure with mildly reduced or preserved ejection fraction (`cardio:hfpef`)
- Registry condition terms include this condition: Heart failure with reduced ejection fraction (HFrEF) (`cardio:hfref`)
- Registry intervention name matches this record: CardioMEMS HF System (`cardio:cardiomems-hf-system`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Hemodynamic-Guided Heart Failure Management in Patients With Either Prior HF Hospitalization or Elevated Natriuretic Peptides (`cardio:pubmed-37286262`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6a6db8658797ab571cf62cab0fc2240050b2c281870d59ad3fbd913b4250d3f2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
